2013
DOI: 10.4014/kjmb.1208.08010
|View full text |Cite
|
Sign up to set email alerts
|

Purification and Characterization of a Fibrinolytic Enzyme Produced by Bacillus amyloliquefaciens HC188

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In addition, Hsia et al 45 demonstrated that oral administration of two capsules of nattokinase (2000 fibrinolysis units per capsule) daily for two months decreases fibrinogen, factor VII, and factor VIII by about 7-19% in healthy humans and patients with cardiovascular risk factors. Chungkookjang has also shown thrombolysis in vitro studies 46,47 and it may have thrombolysis in vivo activity in animals. In the present study, Chungkookjang may have contributed to the attenuated neuronal cell death by preventing thrombosis, although thrombosis may not be a major casual factor for cerebral ischemia in the transient artery occlusion animal model.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, Hsia et al 45 demonstrated that oral administration of two capsules of nattokinase (2000 fibrinolysis units per capsule) daily for two months decreases fibrinogen, factor VII, and factor VIII by about 7-19% in healthy humans and patients with cardiovascular risk factors. Chungkookjang has also shown thrombolysis in vitro studies 46,47 and it may have thrombolysis in vivo activity in animals. In the present study, Chungkookjang may have contributed to the attenuated neuronal cell death by preventing thrombosis, although thrombosis may not be a major casual factor for cerebral ischemia in the transient artery occlusion animal model.…”
Section: Discussionmentioning
confidence: 99%